181 related articles for article (PubMed ID: 6788883)
1. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen.
Streilein JW; Niederkorn JY
J Exp Med; 1981 May; 153(5):1058-67. PubMed ID: 6788883
[TBL] [Abstract][Full Text] [Related]
2. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.
Niederkorn JY; Streilein JW
J Immunol; 1982 Jun; 128(6):2470-4. PubMed ID: 6804562
[TBL] [Abstract][Full Text] [Related]
3. Alloantigen presentation to the anterior chamber of the eye subverts specific in vitro cell-mediated immune responses.
Whittum JA; Niederkorn JY; Streilein JW
Transplantation; 1982 Oct; 34(4):190-5. PubMed ID: 6183804
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
Streilein JW; Niederkorn JY
J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
[TBL] [Abstract][Full Text] [Related]
5. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
6. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
Niederkorn J; Streilein JW; Shadduck JA
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034
[TBL] [Abstract][Full Text] [Related]
7. Termination of immune privilege in the anterior chamber of the eye when tumor-infiltrating lymphocytes acquire cytolytic function.
Ksander BR; Mammolenti MM; Streilein JW
Transplantation; 1991 Jul; 52(1):128-33. PubMed ID: 1907041
[TBL] [Abstract][Full Text] [Related]
8. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
Niederkorn JY; Streilein JW
J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
[TBL] [Abstract][Full Text] [Related]
9. Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye.
Niederkorn JY; Streilein JW
Transplantation; 1982 Jun; 33(6):573-7. PubMed ID: 6808721
[TBL] [Abstract][Full Text] [Related]
10. Induction of delayed hypersensitivity to alloantigens coinjected with Langerhans cells into the anterior chamber of the eye. Abrogation of anterior chamber-associated immune deviation.
Williamson JS; Streilein JW
Transplantation; 1989 Mar; 47(3):519-24. PubMed ID: 2493700
[TBL] [Abstract][Full Text] [Related]
11. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
Niederkorn JY; Mayhew E
Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
[TBL] [Abstract][Full Text] [Related]
12. Immunogenetic basis for immunologic privilege in the anterior chamber of the eye.
Niederkorn JY; Shadduck JA; Streilein JW
Immunogenetics; 1981; 13(3):227-36. PubMed ID: 6792066
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of immunity to intraocular tumors in mice.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):336-42. PubMed ID: 6421767
[TBL] [Abstract][Full Text] [Related]
14. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.
Ferguson TA; Herndon JM
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors.
Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486
[TBL] [Abstract][Full Text] [Related]
16. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
Wilbanks GA; Mammolenti M; Streilein JW
Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
[TBL] [Abstract][Full Text] [Related]
17. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens.
Streilein JW; Niederkorn JY; Shadduck JA
J Exp Med; 1980 Oct; 152(4):1121-5. PubMed ID: 6775039
[TBL] [Abstract][Full Text] [Related]
18. Incomplete activation of lymphokine-producing T cells by alloantigenic intraocular tumours in anterior chamber-associated immune deviation.
Bando Y; Ksander BR; Streilein JW
Immunology; 1993 Feb; 78(2):266-72. PubMed ID: 8097183
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 abrogates anterior chamber-associated immune deviation.
Benson JL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
[TBL] [Abstract][Full Text] [Related]
20. Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye.
Takahashi M; Ishimaru N; Yanagi K; Saegusa K; Haneji N; Shiota H; Hayashi Y
Clin Exp Immunol; 1999 May; 116(2):231-7. PubMed ID: 10337012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
